Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Associations between different types of chronic lesions and gray matter atrophy in multiple sclerosis.
Metformin attenuates developmental myelination.
Neuroinflammatory Biomarkers in Neurodegenerative Disease Diagnosis and Progression.
Four-Year Cognitive Outcomes in Multiple Sclerosis: Associations With Lesion Myelin Integrity.
APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer's disease.
Matrix Matters: Head-To-Head Concordance of Serum and Plasma for NULISAseq CNS Disease Panel.
Feasibility of applying generative AI to create managed care pharmacy formulary reviews.
Pages
« first
‹ previous
…
1145
1146
1147
1148
1149
1150
1151
1152
1153